Acid-sensitive PEGylated Cabazitaxel Prodrugs for Antitumor Therapy

Tao Liu,Hui Zou,Jingqing Mu,Na Yu,Yang Xu,Guohua Liu,Xingjie Liang,Shutao Guo
DOI: https://doi.org/10.1016/j.cclet.2020.12.008
2021-01-01
Abstract:Although the antitumor drug cabazitaxel shows great therapeutic potential,its high toxicity and poor water solubility limit its utility.However,the use of stimuli-responsive prodrugs is a promising strategy for overcoming these limitations.Herein,we report the synthesis of two highly water soluble,acidsensitive PEGylated acyclic-ketal-linked cabazitaxel prodrugs(PKCs) with improved antitumor e fficacy.In an acidic tumor microenvironment,the PKCs hydrolyzed rapidly to release the native drug,whereas they were stable in the normal physiological enviro nment.Compared with cabazitaxel injection,the PKCs had much higher maximum tolerated doses;and in an MDA-MB-231 subcutaneous xenograft nude mouse model,the PKCs showed better antitumor efficacy and safety than cabazitaxel injection.The prodrug strategy reported herein could be useful for the development of other water soluble,acidsensitive prodrugs with improved efficacy.
What problem does this paper attempt to address?